Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
暂无分享,去创建一个
Alan S Maisel | James McCord | Alan H B Wu | J. Hollander | A. Wu | W. Abraham | H. Herrmann | P. Krishnaswamy | R. Kazanegra | P. Clopton | A. Maisel | P. Steg | A. Storrow | R. Nowak | T. Omland | P. McCullough | Alan B Storrow | Judd E Hollander | Howard C Herrmann | Peter A McCullough | Paul Clopton | William T Abraham | J. McCord | P. Duc | A. Westheim | C. Knudsen | A. Perez | Torbjørn Omland | Padma Krishnaswamy | Richard M Nowak | Philippe Duc | Philippe G Steg | Arne Westheim | Catherine Wold Knudsen | Alberto Perez | Radmila Kazanegra
[1] M. Bristow,et al. Economic impact of heart failure in the United States: time for a different approach. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[2] P E Leaverton,et al. Prevalence and mortality rate of congestive heart failure in the United States. , 1992, Journal of the American College of Cardiology.
[3] T. MacDonald,et al. Echocardiography in chronic heart failure in the community. , 1993, The Quarterly journal of medicine.
[4] Thomas D. Giles,et al. Consensus recommendations for the management of chronic heart failure: Introduction , 1999 .
[5] R. Hetzer,et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. , 2001, Journal of the American College of Cardiology.
[6] M. Emdin,et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure , 1998, Journal of endocrinological investigation.
[7] M. Kinoshita,et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. , 1998, American heart journal.
[8] J A Swets,et al. Enhancing and Evaluating Diagnostic Accuracy , 1991, Medical decision making : an international journal of the Society for Medical Decision Making.
[9] D. Morrow,et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes☆ , 2002 .
[10] M. Sorrentino,et al. Causes of congestive heart failure. Prompt diagnosis may affect prognosis. , 1997, Postgraduate medicine.
[11] M. Sabatine,et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. , 2001, The New England journal of medicine.
[12] L. Lenert,et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. , 2001, Journal of the American College of Cardiology.
[13] L. Morrison,et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. , 2002, Annals of emergency medicine.
[14] J. McMurray,et al. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction , 1996, BMJ.
[15] K. Nakao,et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. , 1995, The Journal of clinical investigation.
[16] D. Fukai,et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. , 1997, Circulation.
[17] F. Tristani,et al. Ejection Fraction, Peak Exercise Oxygen Consumption, Cardiothoracic Ratio, Ventricular Arrhythmias, and Plasma Norepinephrine as Determinants of Prognosis in Heart Failure , 1993, Circulation.
[18] J. Oesterling,et al. Predictive properties of serum-prostate-specific antigen testing in a community-based setting. , 1996, Archives of internal medicine.
[19] M. Drazner,et al. Outcomes after emergency department discharge with a primary diagnosis of heart failure. , 2001, American heart journal.
[20] K. Swedberg,et al. Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.
[21] P. Poole‐Wilson,et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care , 1997, The Lancet.
[22] J. Remes,et al. Validity of clinical diagnosis of heart failure in primary health care. , 1991, European heart journal.
[23] N. Minamino,et al. Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide. , 1989, Biochemical and biophysical research communications.
[24] N. Minamino,et al. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. , 1988, Biochemical and biophysical research communications.
[25] R. T. Lie,et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. , 1996, Circulation.
[26] L Irwig,et al. Meta-analysis of Pap test accuracy. , 1995, American journal of epidemiology.
[27] P. Krishnaswamy,et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. , 2001, American heart journal.
[28] R. Devereux,et al. Recommendations Concerning Use of Echocardiography in Hypertension and General Population Research , 1987, Hypertension.
[29] M. Packer,et al. Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure. , 1999, The American journal of cardiology.
[30] L. Stevenson,et al. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.
[31] M. Redfield,et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. , 1998, American journal of physiology. Heart and circulatory physiology.
[32] A. DeMaria,et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction , 2001 .
[33] L. Morrison,et al. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea ☆ , 2002 .
[34] J. Mair,et al. The Impact of Cardiac Natriuretic Peptide Determination on the Diagnosis and Management of Heart Failure , 2001, Clinical chemistry and laboratory medicine.
[35] K. Kugiyama,et al. Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure , 1994, Circulation.
[36] A. Richards,et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea , 1994, The Lancet.
[37] L. Lenert,et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. , 2001, Journal of the American College of Cardiology.